
Trinity Biotech plc TRIB
$ 0.64
-0.82%
Annual report 2024
added 04-25-2026
Country |
|
IPO year |
1992 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
- |
Market Cap[1] |
$ 61.9 M |
EBITDA (LTM) |
$ 3.56 M |
P/E (LTM) |
0.09 |
P/S (LTM) |
1.23 |
EPS (LTM) |
6.9 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 115.62 | 0.06 % | $ 35.1 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 1.65 | -1.2 % | $ 2.19 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 24.98 | 2.13 % | $ 694 M | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
CareDx, Inc
CDNA
|
$ 21.85 | 2.92 % | $ 1.16 B | Nasdaq Global Market,SPB | ||
|
Illumina
ILMN
|
$ 128.52 | 0.5 % | $ 20.4 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 15.6 | -4.35 % | $ 472 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Lantheus Holdings
LNTH
|
$ 84.11 | -0.26 % | $ 5.68 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 171.23 | 0.86 % | $ 8.49 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 421.37 | 2.64 % | $ 12.2 B | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 88.5 | -0.46 % | $ 11.1 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.54 | 0.25 % | $ 20 B | NYSE | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Personalis
PSNL
|
$ 5.96 | -2.3 % | $ 353 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.93 | -2.08 % | $ 8.54 M | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 7.27 | 3.12 % | $ 303 M | NYSE American | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Soleno Therapeutics
SLNO
|
$ 52.75 | 0.06 % | $ 2.68 B | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Neogen Corporation
NEOG
|
$ 9.45 | -0.94 % | $ 2.05 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.18 | 1.87 % | $ 5.01 M | Nasdaq Capital Market | ||
|
National Research Corporation
NRC
|
$ 17.11 | -0.7 % | $ 383 M | Nasdaq Global Select Market | ||
|
Thermo Fisher Scientific
TMO
|
$ 468.04 | -0.36 % | $ 176 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 103.21 | 1.02 % | $ 8.51 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 263.43 | -0.12 % | $ 21.9 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 125.68 | 3.84 % | $ 5.88 B | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 61.0 | 0.1 % | $ 3.65 B | Nasdaq Global Select Market,SPB | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
NeoGenomics
NEO
|
$ 8.61 | 3.86 % | $ 1.1 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.83 | 1.05 % | $ 447 M | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 204.39 | 0.31 % | $ 20.1 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 196.63 | 0.21 % | $ 21.8 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.